Development Strategies for Expediting Time-to-Market of Spray Dried Amorphous Solid Dispersions

Previously Aired on March 10th, 2021

Sign Up:

First Name *

* Required

Last Name *

* Required

Company *

* Required

Address *

* Required

City *

* Required

State *

* Required

Post Code or Zip *

* Required

Country *

* Required

Email *

* Required

Work Emails Only. Registrants using a Personal Email address (gmail, yahoo, etc.), can be contacted for validation.

* Required

Work Phone *

* Required

Job Title *

* Required

May we contact you by email? *

YesNo * Required

Would you like to receive more content from American Pharmaceutical Review? Please select below *

I agree for the Hovione team to contact me by e-mail and telephone to inform me of events, products, services and promotions offered in connection with Hovione.
I can withdraw my consent and unsubscribe at any time by e-mailing HovioneCommunications@hovione.com. By submitting my data, I give consent to the collection, processing and use of my personal data in accordance with the Hovione Privacy Policy (hovione.com/privacy-policy). *

I agree * Required

The webinar sponsor and CompareNetworks may use the information you have provided to contact you about this webinar and other related topics. For more information please refer to our privacy policy.

* Required

(*) denotes required form field(s)

Our registration process uses cookies, by submitting this registration form you agree to our cookie policy.

Overview

Spray drying is a continuous and scalable manufacturing process commonly used in the pharmaceutical industry. In this webinar we will provide an overview of the challenges and opportunities in developing spray dried dispersions (SDDs) and how lab-scale experiments, risk assessment tools and process development experience are key to a successful process development program.

A roadmap of the spray drying development process will be presented, with all the main step to bring a new formulation to the market. A focus will be given to the importance of lab-scale familiarization and supporting studies through the development process and how computational, statistical tools combined with prior knowledge can be capitalized to reduce risk while maximizing time and resources.

Key Learning objectives:

Linking process parameters to critical quality attributes and how to address them during development

Hovione’s methodologies to address the process development of a new formulation

Strategies and tools to minimize risk while minimizing time and costs on the road to commercial

Who should attend:

Type of Companies: Pharmaceutical companies, R&D centers

Job Functions: Head/Director/ Vice President, R&D, CMC, Product Development, Supply Chain

Presenters

João Pires, PhD

(Presenter)
Scientist – Particle Engineering
R&D Drug Product Development
View Biography

Paulo Francisco, PhD

(Presenter)
Scientist – Particle Engineering
R&D Oral Drug Product Development
View Biography

Mike Auerbach

(Moderator)
Editor-in-Chief,
American Pharmaceutical Review